酶响应设计与光动力学疗法相结合,用于治疗癌症
Siying Zhi1, Meixin Huang1, Kui Cheng1
1Guangdong Provincial Key Laboratory of New Drug Screening and NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Drug discovery today
|March 29, 2024
概括
酶反应药物与光动力学疗法 (PDT) 结合,通过克服药物向不良和瘤缺氧等问题,为改善癌症治疗提供了新的途径.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
背景情况:
- 光动力疗法 (PDT) 是一种有前途的非侵入性癌症治疗方法.
- 目前PDT的局限性包括光敏化剂 (PS) 的水性,向不良和瘤缺氧.
- 酶反应药物为应对这些挑战提供了一种新的策略.
研究的目的:
- 审查癌症治疗的酶响应材料的最新进展.
- 要突出酶响应药物与PDT的协同应用.
- 讨论这些组合如何提高治疗效果.
主要方法:
- 对酶反应性材料及其与PDT整合的文献综述.
- 对有针对性的药物输送和选择性药物释放策略的分析.
- 检查表明在临床前模型中改善结果的研究.
主要成果:
- 酶响应系统使光敏感剂 (PSs) 的向输送成为可能.
- 在瘤部位选择性释放药物增强了治疗效果.
- 组合疗法克服了传统PDT的局限性,改善了瘤微环境条件.
结论:
- 酶响应性材料为推进癌症治疗的PDT提供了重要的潜力.
- 有针对性的输送和受控释放是提高疗效的关键好处.
- 这种方法有望为更有效,更少毒性的癌症疗法提供希望.
关键词:
矩阵金属蛋白酶是一种金属蛋白酶.卡瑟普辛B B的情况酶响应药物是一种酶响应药物.氨酸化剂 (hyaluronidase) 是一种亚降解酶的使用方法光动力学疗法是一种光动力学疗法.光敏化剂的光敏化剂.更多相关视频
09:45Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
8.5K
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.3K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
